These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 19303679

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial.
    Deegens JK, Wetzels JF.
    Kidney Int; 2011 Oct; 80(8):798-801. PubMed ID: 21960168
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis.
    Aviles DH, Irwin KC, Dublin LS, Vehaskari VM.
    Pediatr Nephrol; 1999 May; 13(4):298-300. PubMed ID: 10454777
    [Abstract] [Full Text] [Related]

  • 66. Immunosuppressive therapy in primary glomerulonephritides (discussion).
    Contrib Nephrol; 1982 May; (34):64-70. PubMed ID: 6756781
    [No Abstract] [Full Text] [Related]

  • 67. An unusual case of testicular pain.
    MacIver H, Hordon L.
    Clin Rheumatol; 2009 Mar; 28(3):351-2. PubMed ID: 19067102
    [Abstract] [Full Text] [Related]

  • 68. FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy.
    De Smet E, Rioux JP, Ammann H, Déziel C, Quérin S.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2938-40. PubMed ID: 19509024
    [Abstract] [Full Text] [Related]

  • 69. Polymyositis with pulmonary and renal involvement refractory to combined immunosuppressive therapy treated with rituximab.
    Barešić M, Bakula M, Anić B.
    Clin Exp Rheumatol; 2016 Sep; 34(4):720. PubMed ID: 27156519
    [No Abstract] [Full Text] [Related]

  • 70. [Physiopathology and treatment of focal segmental glomerulosclerosis].
    Dohi K.
    Nihon Naika Gakkai Zasshi; 2000 Sep 10; 89(9):2003-9. PubMed ID: 11051685
    [No Abstract] [Full Text] [Related]

  • 71. THE METABOLOMICS SIGNATURE ASSOCIATED WITH RESPONSIVENESS TO STEROID THERAPY IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS: A PILOT STUDY.
    Chashmniam S, Kalantari S, Nafar M, Boroumandnia N.
    Rev Invest Clin; 2019 Sep 10; 71(2):106-115. PubMed ID: 31056594
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts.
    Shi J, Jun W, Zhao LY, Xue YX, Zhang XY, Kosten TR, Lu L.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):108-12. PubMed ID: 19470385
    [Abstract] [Full Text] [Related]

  • 75. Cyclosporine--a treatment and a rare complication: Raynaud's phenomenon.
    Arinsoy T, Derici U, Yuksel A, Reis KA, Sindel S.
    Int J Clin Pract; 2005 Jul 01; 59(7):863-4. PubMed ID: 15963220
    [No Abstract] [Full Text] [Related]

  • 76. TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis.
    Santín S, Ars E, Rossetti S, Salido E, Silva I, García-Maset R, Giménez I, Ruíz P, Mendizábal S, Luciano Nieto J, Peña A, Camacho JA, Fraga G, Cobo MA, Bernis C, Ortiz A, de Pablos AL, Sánchez-Moreno A, Pintos G, Mirapeix E, Fernández-Llama P, Ballarín J, Torra R, FSGS Study Group, Zamora I, López-Hellin J, Madrid A, Ventura C, Vilalta R, Espinosa L, García C, Melgosa M, Navarro M, Giménez A, Cots JV, Alexandra S, Caramelo C, Egido J, San José MD, de la Cerda F, Sala P, Raspall F, Vila A, Daza AM, Vázquez M, Ecija JL, Espinosa M, Justa ML, Poveda R, Aparicio C, Rosell J, Muley R, Montenegro J, González D, Hidalgo E, de Frutos DB, Trillo E, Gracia S, de los Ríos FJ.
    Nephrol Dial Transplant; 2009 Oct 01; 24(10):3089-96. PubMed ID: 19458060
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.
    Perl AE, Kasner MT, Tsai DE, Vogl DT, Loren AW, Schuster SJ, Porter DL, Stadtmauer EA, Goldstein SC, Frey NV, Nasta SD, Hexner EO, Dierov JK, Swider CR, Bagg A, Gewirtz AM, Carroll M, Luger SM.
    Clin Cancer Res; 2009 Nov 01; 15(21):6732-9. PubMed ID: 19843663
    [Abstract] [Full Text] [Related]

  • 79. Tacrolimus for the treatment of focal segmental glomerulosclerosis resistant to cyclosporine A.
    Suzuki K, Tsugawa K, Tanaka H.
    Pediatr Nephrol; 2006 Dec 01; 21(12):1913-4. PubMed ID: 16897001
    [No Abstract] [Full Text] [Related]

  • 80. Lung cavitation due to Mycobacterium xenopi in a renal transplant recipient.
    Martín-Penagos L, Rodrigo E, Ruíz JC, Agüero J, Fernandez-Mazarrasa C, Martínez L, Piñera C, Arias M.
    Transpl Infect Dis; 2009 Jun 01; 11(3):249-52. PubMed ID: 19298241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.